Omega Healthcare Investors (OHI) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
3 Jun, 2026Company profile and strategy
Listed since 1992, with $18.2B enterprise value and $11.6B in real estate investments.
Operates 1,124 properties across the US, UK, and Jersey, with 94 operators and 102,180 beds.
Investment grade (BBB-) with an 84% 5-year total shareholder return and 6.1% dividend yield.
Differentiators include largest SNF-focused REIT, consistent dividend growth, and diversified tenant base.
Leadership transition planned for 2026, with proven management and strong governance.
Investment thesis and portfolio strengths
Diversified portfolio with long-term triple net leases and limited new supply.
Consistent high-yield growth, strong balance sheet, and significant liquidity.
Well-positioned for future growth due to aging demographics and operator relationships.
Trades at 13.3x AFFO with 6.6% annualized AFFO growth since 2004.
Skilled nursing facilities (SNFs) market dynamics
SNFs are the primary discharge destination for Medicare patients, offering lowest cost 24-hour post-acute care.
Primarily funded by Medicare and Medicaid, with steady reimbursement growth.
Limited supply growth due to regulatory restrictions, supporting occupancy and pricing.
SNFs deliver highest investment yields among healthcare real estate assets.
Latest events from Omega Healthcare Investors
- Board and auditor approvals, asset sale rationale, and dividend policy updates highlighted.OHI
AGM 202610 Jun 2026 - CEO and CFO transitions in 2026 include succession plans, incentives, and consulting agreements.OHI
Proxy filing21 May 2026 - Q1 2026 saw strong earnings growth, higher AFFO, and increased guidance amid robust investment activity.OHI
Q1 202629 Apr 2026 - Proxy details strong 2025 results, performance-based pay, and leadership in ESG and governance.OHI
Proxy filing21 Apr 2026 - Key votes include director elections, auditor ratification, and executive pay approval.OHI
Proxy filing21 Apr 2026 - Strong Q4 and 2025 results, major investments, and a positive 2026 outlook with low leverage.OHI
Q4 202513 Apr 2026 - Consistent high-yield growth, strong financials, and demographic tailwinds drive expansion.OHI
Investor presentation5 Feb 2026 - Q2 net income and FFO rose, AFFO guidance increased, but operator and regulatory risks remain.OHI
Q2 20242 Feb 2026 - Q3 FAD and net income rose, AFFO guidance raised, but operator and regulatory risks persist.OHI
Q3 202417 Jan 2026